Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Drug News & Perspectives|January 8, 2008
Emerging therapies for respiratory diseasesRuth Lock, Steve Collingwood, Andrew RatcliffeDrug News & Perspectives|April 19, 2007
Therapeutic approaches towards the treatment of gastroinstestinal disordersSteve Collingwood, Jason WitheringtonJournal of the Intensive Care Society|February 20, 2018
Successful management of 70% acetic acid ingestion on the intensive care unit: A case reportAndrew Ratcliffe, Andrew Baker, Daniel SmithBurns : Journal of the International Society for Burn Injuries|July 3, 2014
Comparison of mortality prediction models in burns ICU patients in Pinderfields Hospital over 3 yearsHelen E Douglas, Andrew Ratcliffe, Rajdeep Sandhu, et al.Toxicology and Applied Pharmacology|June 1, 2015
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety modelAlexandre Trifilieff, Brian T Ethell, David A Sykes, et al.Journal of Clinical Pharmacology|March 7, 2022
The Effect of Hepatic Impairment on the Pharmacokinetics of Intravenously Administered Felcisetrag (TAK-954)Richard Czerniak, Blanka Cieslarová, Viera Kupčová, et al.Clinical Pharmacology in Drug Development|January 6, 2022
Evaluation of the Pharmacokinetics of Felcisetrag (TAK-954), a 5-HT4 Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 InhibitorChunlin Chen, Liming Zhang, Cristina Almansa, et al.European Journal of Drug Metabolism and Pharmacokinetics|December 24, 2024
Mass Balance Recovery, Absorption, Metabolism, and Excretion of Elinzanetant in Healthy Human Volunteers and in vitro BiotransformationSimone I Schulz, Marcus-Hillert Schultze-Mosgau, Anna Engelen, et al.Chest|February 16, 2013
Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosisSteven M Rowe, Ginger Reeves, Heather Hathorne, et al.Advanced Drug Delivery Reviews|December 15, 2010
Challenges in inhaled product development and opportunities for open innovationBen Forbes, Bahman Asgharian, Lea Ann Dailey, et al.Pageof 2